Literature DB >> 1644855

Role of vitamin D in bone resorption.

T Suda1, N Takahashi, E Abe.   

Abstract

The idea that vitamin D must function at the bone site to promote bone mineralization has long existed since its discovery as an anti-rachitic agent. However, the definite evidence for this is still lacking. In contrast, much evidence has accumulated that 1 alpha,25(OH)2D3 in involved in bone resorption. 1 alpha,25(OH)2D3 tightly regulates differentiation of osteoclast progenitors into osteoclasts. Osteoclast progenitors have been thought to belong to the monocyte-macrophage lineage. 1 alpha,25(OH)2D3 greatly stimulates differentiation and activation of mononuclear phagocytes. Recent reports have indicated that differentiation of mononuclear phagocytes into osteoclasts is strictly regulated by osteoblastic cells, the process of which is also stimulated by 1 alpha,25(OH)2D3. In the differentiation of mononuclear phagocytes into osteoclasts, the target cells for 1 alpha,25(OH)2D3 appear to be osteoblastic stromal cells. Osteoblastic cells produce several proteins such as BGP, MGP, osteopontin and the third component of complement (C3) in response to the vitamin. They appear to be somehow involved in osteoclast differentiation and functions. Thus, 1 alpha,25(OH)2D3 seems to be involved in the differentiation of osteoclast progenitors into osteoclasts directly and also by an indirect mechanism involving osteoblastic cells. The precise role of osteoblastic cells in osteoclast development has to be elucidated in the future.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644855     DOI: 10.1002/jcb.240490110

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

Review 1.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 2.  Mechanism of Bone Mineralization.

Authors:  Monzur Murshed
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

3.  Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.

Authors:  F F Safadi; D C Hermey; S N Popoff; M F Seifert
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

4.  Expression of osteoblastic markers in cultured human bone and fracture callus cells.

Authors:  M Mörike; M Schulz; A Nerlich; M Koschnik; W M Teller; U Vetter; R E Brenner
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 5.  Vitamin D and bone.

Authors:  Daniel D Bikle
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

Review 6.  Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.

Authors:  G Jones; D B Hogan; E Yendt; D A Hanley
Journal:  CMAJ       Date:  1996-10-01       Impact factor: 8.262

Review 7.  A novel vitamin D-regulated immediate-early gene, IEX-1, alters cellular growth and apoptosis.

Authors:  Rajiv Kumar; Mark R Pittelkow; Jeffrey L Salisbury; Joseph P Grande; Hee-Jeong Im; Kathrin A Feldmann; David Schilling
Journal:  Recent Results Cancer Res       Date:  2003

8.  Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription.

Authors:  Sayyed K Zaidi; Andrew J Sullivan; Ricardo Medina; Yoshiaki Ito; Andre J van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

Review 9.  Calcium metabolism and vitamin D in the extreme longevity.

Authors:  Giovanni Passeri; Rosanna Vescovini; Paolo Sansoni; Carlo Galli; Claudio Franceschi; Mario Passeri
Journal:  Exp Gerontol       Date:  2007-07-04       Impact factor: 4.032

10.  Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3 in vivo.

Authors:  Dengshun Miao; Andrew Scutt
Journal:  BMC Musculoskelet Disord       Date:  2002-06-07       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.